Fig 1.
Flow chart of participants’ analysis.
Fig 2.
Map showing the proportion distribution of study participants per region.
The map shows 26 Tanzania mainland administrative regions. (This map was adapted from the Tanzania NBS): (https://www.nbs.go.tz/nbs/takwimu/references/Licence-Agreement-NBS.pdf).
Table 1.
Participants’ demographic and clinical characteristics (N = 56,004).
Table 2.
Frequency and distribution of specific rpoB gene mutations (N = 219).
Table 3.
Demographic and clinical characteristics of the number of no-missing probe study participants (N = 231).
Table 4.
Distribution of rifampicin resistance and participants’ characteristics (N = 56,004).
Table 5.
Multivariate logistic regression analysis for the predictors of Rifampicin resistance.